Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 6;27(11):3635.
doi: 10.3390/molecules27113635.

New Advances in Short Peptides: Looking Forward

Affiliations
Editorial

New Advances in Short Peptides: Looking Forward

Vasso Apostolopoulos et al. Molecules. .

Abstract

It is beyond doubt that short peptides hold significant promise in bio-medicine, as the most versatile molecules, both structurally and functionally [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Apostolopoulos V., Bojarska J., Chai T.-T., Elnagdy S., Kaczmarek K., Matsoukas J., New R., Parang K., Lopez O.P., Parhiz H., et al. A Global Review on Short Peptides: Frontiers and Perspectives. Molecules. 2021;26:430. doi: 10.3390/molecules26020430. - DOI - PMC - PubMed
    1. Bojarska J., Mieczkowski A., Ziora Z.M., Skwarczynski M., Toth I., Shalash A.O., Parang K., El-Mowafi S.A., Mohammed E.H.M., Elnagdy S., et al. Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold. Biomolecules. 2021;11:1515. doi: 10.3390/biom11101515. - DOI - PMC - PubMed
    1. Apostolopoulos V., Bojarska J., Feehan J., Matsoukas J., Wolf W.M. Smart therapies for pandemics: A potential of short peptides. Front. Pharmacol. :2022. submitted . - PMC - PubMed
    1. Skwarczynski M., Bashiri S., Yuan Y., Ziora Z.M., Nabil O., Masuda K., Khongkow M., Rimsueb N., Cabral H., Ruktanonchai U., et al. Antimicrobial Activity Enhancers: Towards Smart Delivery of Antimicrobial Agents. Antibiotics. 2022;11:412. doi: 10.3390/antibiotics11030412. - DOI - PMC - PubMed
    1. Ridgway H., Moore G.J., Mavromoustakos T., Tsiodras S., Ligielli I., Kelaidonis K., Chasapis C.C., Gadanec L.K., Zulli A., Apostolopoulos V., et al. Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Comput. Struct. Biotechnol. J. 2022;20:2091. doi: 10.1016/j.csbj.2022.04.010. - DOI - PMC - PubMed

Publication types

LinkOut - more resources